165 related articles for article (PubMed ID: 16712930)
1. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
3. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
[TBL] [Abstract][Full Text] [Related]
5. Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.
Ismail EA; El-Mogy MI; Mohamed DS; El-Farrash RA
J Pediatr Hematol Oncol; 2011 Oct; 33(7):534-42. PubMed ID: 21423046
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
[TBL] [Abstract][Full Text] [Related]
8. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia].
Zemliakova VV; Strel'nikov VV; Zborovskaia IB; Balukova OV; Maĭorova OA; Vasil'ev EV; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2004; 38(6):966-72. PubMed ID: 15612580
[TBL] [Abstract][Full Text] [Related]
13. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
16. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction.
Pine SR; Yin C; Matloub YH; Sabaawy HE; Sandoval C; Levendoglu-Tugal O; Ozkaynak MF; Jayabose S
J Mol Diagn; 2005 Feb; 7(1):127-32. PubMed ID: 15681484
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia.
Garcia-Manero G; Jeha S; Daniel J; Williamson J; Albitar M; Kantarjian HM; Issa JP
Cancer; 2003 Feb; 97(3):695-702. PubMed ID: 12548613
[TBL] [Abstract][Full Text] [Related]
19. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
